{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:58:00Z","timestamp":1786993080610,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K07281"],"award-info":[{"award-number":["21K07281"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10672"],"award-info":[{"award-number":["24K10672"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jns.2026.126039","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:11:40Z","timestamp":1780503100000},"page":"126039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association of anti-glycolipid IgG with respiratory function decline in amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"488","author":[{"given":"Junji","family":"Nakasako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Yaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Terayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10360","key":"10.1016\/j.jns.2026.126039_bb0005","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2026.126039_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jns.2026.126039_bb0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2022.0901","article-title":"Efficacy and safety of ultrahigh-dose Methylcobalamin in early-stage amyotrophic lateral sclerosis: a randomized clinical trial","volume":"79","author":"Oki","year":"2022","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.jns.2026.126039_bb0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium Phenylbutyrate-Taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.jns.2026.126039_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081180","article-title":"Biofluid biomarkers in the prognosis of amyotrophic lateral sclerosis: recent developments and therapeutic applications","volume":"12","author":"Sanchez-Tejerina","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jns.2026.126039_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.753242","article-title":"Plasma and CSF Neurofilament light chain in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study","volume":"13","author":"Vacchiano","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2026.126039_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.26860","article-title":"Biomarker qualification for Neurofilament light chain in amyotrophic lateral sclerosis: theory and practice","volume":"95","author":"Benatar","year":"2024","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2026.126039_bb0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2022.1113","article-title":"TDP-43 accumulation within intramuscular nerve bundles of patients with amyotrophic lateral sclerosis","volume":"79","author":"Kurashige","year":"2022","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126039_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-022-00515-1","article-title":"Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis","volume":"17","author":"Staats","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jns.2026.126039_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.552295","article-title":"Plasma inflammatory cytokines are elevated in ALS","volume":"11","author":"Tortelli","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2026.126039_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jnnp-2017-317077","article-title":"Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials","volume":"89","author":"van Eijk","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.jns.2026.126039_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/21678421.2020.1746810","article-title":"Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis","volume":"21","author":"Mitsumoto","year":"2020","journal-title":"Amyotroph. Lateral Scler. Frontotemp. Degener."},{"issue":"4","key":"10.1016\/j.jns.2026.126039_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174925","article-title":"Predicting functional decline and survival in amyotrophic lateral sclerosis","volume":"12","author":"Ong","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jns.2026.126039_bb0070","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","article-title":"Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study","volume":"71","author":"Chi\u00f2","year":"2014","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.jns.2026.126039_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab143","article-title":"Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression","volume":"3","author":"Sol","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.jns.2026.126039_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106851","article-title":"Glycosphingolipids in neurodegeneration - molecular mechanisms, cellular roles, and therapeutic perspectives","volume":"207","author":"H\u00fclsmeier","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2026.126039_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116576","article-title":"Antiganglioside antibodies in neurological diseases","volume":"408","author":"Wanleenuwat","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126039_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.760889","article-title":"Anti-ganglioside antibodies in Guillain-Barre syndrome: a novel immunoblotting-panel assay","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Neurol."},{"issue":"Pt 12","key":"10.1016\/j.jns.2026.126039_bb0095","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"issue":"26","key":"10.1016\/j.jns.2026.126039_bb0100","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1073\/pnas.1508767112","article-title":"Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis","volume":"112","author":"Dodge","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jns.2026.126039_bb0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0074-7742(09)85022-8","article-title":"Neurotrophic and neuroprotective actions of an enhancer of ganglioside biosynthesis","volume":"85","author":"Inokuchi","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"issue":"3","key":"10.1016\/j.jns.2026.126039_bb0110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jnr.490380305","article-title":"Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside","volume":"38","author":"Yim","year":"1994","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.jns.2026.126039_bb0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cen3.12007","article-title":"Pathogenic roles of antiganglioside antibodies in immune-mediated neuropathies","volume":"4","author":"Kaida","year":"2013","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.jns.2026.126039_bb0120","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.clinph.2016.04.005","article-title":"Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data","volume":"127","author":"Geevasinga","year":"2016","journal-title":"Clin. Neurophysiol."},{"issue":"5\u20136","key":"10.1016\/j.jns.2026.126039_bb0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: a critical review","volume":"10","author":"Chi\u00f2","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jns.2026.126039_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102674","article-title":"Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis","volume":"30","author":"Steinbach","year":"2021","journal-title":"Neuroimage Clin."},{"issue":"5","key":"10.1016\/j.jns.2026.126039_bb0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","article-title":"N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barr\u00e9 syndrome","volume":"35","author":"Kusunoki","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2026.126039_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.125732","article-title":"Evaluating ALSFRS-R as an indicator of disease milestones and functional independence: an observational study of US neurologists and their patients with amyotrophic lateral sclerosis","volume":"481","author":"Mehdiyoun","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126039_bb0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fimmu.2020.00195","article-title":"The role of calcium-Calcineurin-NFAT signaling pathway in health and autoimmune diseases","volume":"11","author":"Park","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jns.2026.126039_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125339","article-title":"Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited","volume":"10","author":"Kollewe","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26003217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26003217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:20:54Z","timestamp":1783603254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26003217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0022510X26003217"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126039","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of anti-glycolipid IgG with respiratory function decline in amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126039"}}